|Global dialysis perspective: India|
J Bharati, V Jha
Kidney360 1 (10), 1143, 2020
|Persistent CD‐19 depletion by rituximab is cost‐effective in maintaining remission in calcineurin‐inhibitor dependent podocytopathy|
R Ramachandran, J Bharati, I Rao, AW Kashif, R Nada, R Minz, KL Gupta, ...
Nephrology 24 (12), 1241-1247, 2019
|Achieving dialysis adequacy: A global perspective|
J Bharati, V Jha
Seminars in Dialysis 33 (6), 490-498, 2020
|The environment and kidney health: challenges and opportunities|
J Bharati, C Zavaleta-Cortijo, T Bressan, A Shingada, G Obrador, L Sola, ...
Salud Pública de México, 1-10, 2022
|Long-term follow-up of cyclical cyclophosphamide and steroids versus tacrolimus and steroids in primary membranous nephropathy|
R Ramachandran, V Kumar, J Bharati, B Rovin, R Nada, V Kumar, ...
Kidney international reports 6 (10), 2653-2660, 2021
|Comparison of two steroid regimens in induction therapy of proliferative lupus nephritis: A randomized controlled trial|
J Bharati, M Rathi, R Ramachandran, A Sharma, V Kumar, H Kohli, ...
Indian Journal of Nephrology 29 (5), 373-375, 2019
|Utility of plasma exchange in early recurrent C3 glomerulopathy|
A Kumar, J Bharati, R Nada, S Singh, A Sharma, KL Gupta, ...
Indian Journal of Transplantation 13 (2), 122, 2019
|Successful treatment of C1q nephropathy with CD19 targeted Rituximab therapy|
R Ramachandran, J Bharati, V Jha
Nephrology 22 (3), 265-265, 2017
|Rituximab in maintaining remission in adults with podocytopathy|
R Ramachandran, J Bharati, R Nada, R Minz, HS Kohli
Nephrology 25 (8), 616-624, 2020
|COVID‐19 pandemic in limited‐resource countries: Strategies for challenges in a dialysis unit|
J Bharati, R Ramachandran, V Kumar, HS Kohli
Nephrology (Carlton, Vic.), 2020
|Usefulness of mycophenolate mofetil in Indian patients with C3 glomerulopathy|
J Bharati, K Tiewsoh, A Kumar, R Nada, M Rathi, KL Gupta, HS Kohli, ...
Clinical kidney journal 12 (4), 483-487, 2019
|C-Terminal fibroblast growth factor-23 levels in non-nutritional hypophosphatemic rickets|
J Bharati, D Bhatia, P Khandelwal, N Gupta, A Sinha, R Khadgawat, ...
The Indian Journal of Pediatrics 86 (6), 555-557, 2019
|Rituximab in treatment of collapsing FSGS—A case series|
N Girimaji, J Bharati, R Nada, M Rathi, HS Kohli, R Ramachandran
Nephrology 26 (2), 134-141, 2021
|18F-FDG PET/CT demonstrates renal cell cancer in a transplant with synchronous intestinal infection|
AJ Kavanal, J Bharati, SK Vadi, KL Gupta, R Kumar, BR Mittal
Clinical Nuclear Medicine 44 (4), e294-e295, 2019
|Global Kidney Health Atlas: a spotlight on the Asia-Pacific sector|
J Bharati, V Jha
Kidney Research and Clinical Practice 41 (1), 22, 2022
|Anti-nuclear antibody-negative lupus nephritis or post-infectious glomerulonephritis: Diagnostic dilemma in a young male|
J Bharati, S Quaiser, R Nada, R Ramachandran, HS Kohli, M Rathi
Indian Journal of Nephrology 31 (4), 394, 2021
|Addison's disease due to histoplasmosis of bilateral adrenal glands in a previously treated extrapulmonary tuberculosis case|
SK Sharma, M Tripathi
The Indian Journal of Medical Research 152 (Suppl 1), S1, 2020
|The Global Kidney Health Atlas: burden and opportunities to improve kidney health worldwide|
J Bharati, V Jha, A Levin
Annals of Nutrition and Metabolism 76 (1), 25-30, 2020
|Membranous nephropathy with light chain restricted deposits|
R Ramachandran, N Inamdar, J Bharati, AK Yadav, A Kumar, G Prakash, ...
Nephrology 23 (8), 791-796, 2018
|Recurrent focal segmental glomerulosclerosis after kidney transplant in adults: A report on various treatment regimens|
J Bharati, KL Gupta, DB Kenwar, R Nada, M Rathi, HS Kohli, ...
Indian Journal of Transplantation 12 (3), 193, 2018